Abstract

Glycohemoglobin assays are important for evaluating long-term glycemic control in patients with diabetes (1). Ion-exchange HPLC is commonly used for measuring hemoglobin A1c (Hb A1c), but hemoglobin variants (Hbvar) or increased fetal Hb concentrations may affect the quantification of Hb A1c by HPLC. The presence of Hbvar or high Hb F concentrations can be recognized by the separate elution of variant peaks or by abnormally high peaks on HPLC, and these abnormal findings arise mostly from genetic alterations in the globin genes (2)(3). In Koreans, only limited data are available on the incidence and molecular genetic background of Hbvar and high Hb F concentrations. We therefore investigated patients who had abnormal peaks on their Hb A1c analyses and characterized them by molecular methods. Of the 27 006 patients who were tested for Hb A1c at Samsung Medical Center in Seoul, Korea, from May 2004 to …

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call